相似文献
1
Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism.
Transfusion. 2021 Sep;61(9):2799-2800. doi: 10.1111/trf.16581. Epub 2021 Jul 5.
2
Convalescent blood plasma (CBP) donated by recovered COVID-19 patients - A comment.
Transfus Apher Sci. 2021 Jun;60(3):103108. doi: 10.1016/j.transci.2021.103108. Epub 2021 Mar 2.
3
Decrease in serum antibodies to SARS-CoV-2 in convalescent plasma donors over time.
Transfusion. 2021 Feb;61(2):651-654. doi: 10.1111/trf.16172.
4
COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience.
Mo Med. 2021 Jan-Feb;118(1):74-80.
5
SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.
J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI148832.
6
Google Trends demonstrate public interest in COVID-19 convalescent plasma therapy.
J Clin Apher. 2021 Jun;36(3):492-493. doi: 10.1002/jca.21862. Epub 2020 Dec 19.
7
Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.
Transfusion. 2021 Jun;61(6):1705-1709. doi: 10.1111/trf.16378. Epub 2021 Mar 22.
8
Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors.
PLoS One. 2022 Feb 24;17(2):e0264124. doi: 10.1371/journal.pone.0264124. eCollection 2022.
9
Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations.
Transfusion. 2021 Jan;61(1):12-16. doi: 10.1111/trf.16119. Epub 2020 Oct 14.
10
Screening donors for COVID-19 convalescent plasma.
Transfusion. 2021 Apr;61(4):1047-1052. doi: 10.1111/trf.16253. Epub 2021 Feb 1.
本文引用的文献
1
COVID-19 convalescent plasma: Interim recommendations from the AABB.
Transfusion. 2021 Apr;61(4):1313-1323. doi: 10.1111/trf.16328. Epub 2021 Mar 7.
2
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
N Engl J Med. 2021 Feb 18;384(7):610-618. doi: 10.1056/NEJMoa2033700. Epub 2021 Jan 6.
3
Growing evidence supports healthy older people continuing to donate blood into later life.
Transfusion. 2019 Apr;59(4):1166-1170. doi: 10.1111/trf.15237.
4
The persistent exclusion of older patients from ongoing clinical trials regarding heart failure.
Arch Intern Med. 2011 Mar 28;171(6):550-6. doi: 10.1001/archinternmed.2011.31.
5
Fighting against age discrimination in clinical trials.
J Am Geriatr Soc. 2010 Sep;58(9):1791-6. doi: 10.1111/j.1532-5415.2010.03032.x.
Zotero 插件